| MDL | - |
|---|---|
| Molecular Weight | 425.60 |
| Molecular Formula | C27H39NO3 |
| SMILES | O=C1[C@]2([H])[C@]3(C)C(C[C@@H](O)CC3)=CC[C@@]2([H])[C@]4([H])CC[C@]5(O[C@@]6([H])[C@@]([C@H]5C)([H])NC[C@@H](C)C6)C(C)=C41 |
IC50: 500-700 nM (Hedgehog) [1]
Jervine (40 μM; 6, 12 and 24 hours) inhibits Akt phosphorylation
[3]
.
Jervine (40 μM; 2 hours) inhibits NF-jB activation decreased COX-2 overexpression and induced apoptosis
[3]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Western Blot Analysis [1]
| Cell Line: | HEL and TF1a cells |
| Concentration: | 40 μM |
| Incubation Time: | 6, 12 and 24 hours |
| Result: | Inhibited Akt phosphorylation. |
Jervine (orally; 50-400 mg/kg) exerts 50.4-73.5% anti-inflammatory effects in carrageenan induced paw edema [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | Male Sprague Dawley rats (180-200 g) [2] |
| Dosage: | 50, 100, 200 and 400 mg/kg |
| Administration: | Orally |
| Result: | Exerted 50.4-73.5% anti-inflammatory effects in carrageenan induced paw edema. |
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 1 mg/mL ( 2.35 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.3496 mL | 11.7481 mL | 23.4962 mL |
| 5 mM | --- | --- | --- |
| 10 mM | --- | --- | --- |